Abstract
STUDY OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors. DESIGN: Postal questionnaire. SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current Principal List of the UK Medical Register. MAIN OUTCOME MEASURES: Current and previous use of HRT; reasons for and against HRT use; menopausal status; hormonal contraceptive use; lifestyle patterns; family and personal history of disease. MAIN RESULTS: While 73.2% of 471 users had started HRT for symptom relief, 60.9% cited prevention of osteoporosis and 32.7 prevention of cardiovascular disease. Altogether 18.7% had started for preventive purposes alone. Significant predisposing factors to starting HRT were the presence and severity of menopausal symptoms, surgical menopause, past use of hormonal contraception, and a family history of osteoporosis. HRT users were also more likely to use skimmed rather than full fat milk, to try to increase their intake of fruit, vegetables, and fibre, and to undertake vigorous physical activity at least once a week. They were less likely to have had breast cancer. Long duration users were more likely than short duration users to be past users of hormonal contraception and to be using HRT for prevention of osteoporosis as well as symptom relief; they were less likely to have experienced side effects. CONCLUSIONS: The high usage of HRT by women doctors reflects the fact that many started HRT on their own initiative and with long term prevention in mind. The results may become generalisable to the wider population as information on the potential benefits of HRT is disseminated and understood. However, HRT users may differ slightly from non-users in health-related behaviour and a substantial minority may never take up HRT, at least until the benefit-risk ratio is more clearly established.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991 Sep 15;115(6):455–456. doi: 10.7326/0003-4819-115-6-455. [DOI] [PubMed] [Google Scholar]
- Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B., Speizer F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15;332(24):1589–1593. doi: 10.1056/NEJM199506153322401. [DOI] [PubMed] [Google Scholar]
- Egeland G. M., Kuller L. H., Matthews K. A., Kelsey S. F., Cauley J., Guzick D. Premenopausal determinants of menopausal estrogen use. Prev Med. 1991 May;20(3):343–349. doi: 10.1016/0091-7435(91)90033-z. [DOI] [PubMed] [Google Scholar]
- Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
- Griffiths F., Jones K. The use of hormone replacement therapy; results of a community survey. Fam Pract. 1995 Jun;12(2):163–165. doi: 10.1093/fampra/12.2.163. [DOI] [PubMed] [Google Scholar]
- Henderson B. E., Paganini-Hill A., Ross R. K. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991 Jan;151(1):75–78. [PubMed] [Google Scholar]
- Isaacs A. J., Britton A. R., McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ. 1995 Nov 25;311(7017):1399–1401. doi: 10.1136/bmj.311.7017.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lancaster T., Surman G., Lawrence M., Mant D., Vessey M., Thorogood M., Yudkin P., Daly E. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Community Health. 1995 Aug;49(4):389–394. doi: 10.1136/jech.49.4.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McPherson K. Breast cancer and hormonal supplements in postmenopausal women. BMJ. 1995 Sep 16;311(7007):699–700. doi: 10.1136/bmj.311.7007.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meade T. W., Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 1992 Apr;48(2):276–308. doi: 10.1093/oxfordjournals.bmb.a072548. [DOI] [PubMed] [Google Scholar]
- Petitti D. B., Perlman J. A., Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol. 1987 Sep;70(3 Pt 1):289–293. [PubMed] [Google Scholar]
- Pilote L., Hlatky M. A. Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J. 1995 Jun;129(6):1237–1238. doi: 10.1016/0002-8703(95)90426-3. [DOI] [PubMed] [Google Scholar]
- Sinclair H. K., Bond C. M., Taylor R. J. Hormone replacement therapy: a study of women's knowledge and attitudes. Br J Gen Pract. 1993 Sep;43(374):365–370. [PMC free article] [PubMed] [Google Scholar]
- Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]
- Steinberg K. K., Thacker S. B., Smith S. J., Stroup D. F., Zack M. M., Flanders W. D., Berkelman R. L. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 1991 Apr 17;265(15):1985–1990. [PubMed] [Google Scholar]
- Villard-Mackintosh L., Vessey M. P., Jones L. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age. Br J Obstet Gynaecol. 1989 Jul;96(7):783–788. doi: 10.1111/j.1471-0528.1989.tb03316.x. [DOI] [PubMed] [Google Scholar]
